Literature DB >> 9236757

The use of oral opioids in patients with chronic non-cancer pain. Management strategies.

P J Graziotti1, C R Goucke.   

Abstract

BACKGROUND: The use of oral opioids in non-cancer pain is increasing, but it is not clear that this is improving outcomes for patients. These management strategies were developed as a consensus view between the two authors, who are both Directors of the Australian Pain Society. The strategies were subsequently reviewed and approved by the other Directors of the Society: four anaesthetists specialising in pain management, a pharmacist, a rheumatologist, two rehabilitation physicians and an occupational therapist. EVIDENCE BASE: A MEDLINE search of the literature since 1966 produced 163 relevant articles, including two randomised controlled trials of oral opioids in non-cancer pain. MANAGEMENT CONSENSUS: A small group of patients with chronic non-cancer pain can benefit from the use of oral opioids. Thorough attention to diagnosis and patient history must precede any decision to prescribe opioids. Patients should be psychologically stable. Patient and doctor should-agree beforehand on how to assess the outcome of therapy. Only one doctor (the patient's regular primary carer or pain specialist) should prescribe opioids and assess the response. Sustained release morphine preparations are the drug of choice. A trial of therapy, with goals and endpoint agreed between patient and doctor, should precede any decision to prescribe opioids in the long term.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236757

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  12 in total

1.  Use of opioids to treat chronic, noncancer pain.

Authors:  B D Dickinson; R D Altman; N H Nielsen; M A Williams
Journal:  West J Med       Date:  2000-02

2.  Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.

Authors:  L Allan; H Hays; N H Jensen; B L de Waroux; M Bolt; R Donald; E Kalso
Journal:  BMJ       Date:  2001-05-12

Review 3.  Risk-benefit assessment of opioids in chronic noncancer pain.

Authors:  B Bannwarth
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

4.  Transdermal fentanyl for the treatment of pain caused by rheumatoid arthritis.

Authors:  Gabriel Herrero-Beaumont; Olav Bjorneboe; Ute Richarz
Journal:  Rheumatol Int       Date:  2004-10-05       Impact factor: 2.631

Review 5.  Transdermal buprenorphine.

Authors:  Hannah C Evans; Stephanie E Easthope
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  Management strategies for the treatment of neuropathic pain in the elderly.

Authors:  Mahmood Ahmad; Charles Roger Goucke
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 7.  Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.

Authors:  G K Gourlay
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

8.  Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre study.

Authors:  Xavier Le Loët; Karel Pavelka; Ute Richarz
Journal:  BMC Musculoskelet Disord       Date:  2005-06-15       Impact factor: 2.362

9.  Development and preliminary validation of the Opioid Abuse Risk Screener.

Authors:  Patricia Henrie-Barrus; Lynnette A Averill; Richard R Sudweeks; Christopher L Averill; Natalie Mota
Journal:  Health Psychol Open       Date:  2016-05-15

Review 10.  Management of chronic pain in the elderly: focus on transdermal buprenorphine.

Authors:  Nalini Vadivelu; Roberta L Hines
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.